Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillNo recent work listed

Autumn J. McRee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0475-1579; OpenAlex author ID A5086781190. Sources: ClinicalTrials.gov.

Their work

Papers
5
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2012: 1 trial · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 5

  1. Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-0391↗
  2. Low-Intensity Focused Ultrasound Produces Immune Response in Pancreatic Cancer. Co-author DOI 10.1016/j.ultrasmedbio.2022.06.017↗
  3. B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-19-0349↗
  4. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreate… Co-author DOI 10.1093/annonc/mdv264↗
  5. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreate… Co-author DOI 10.1093/annonc/mdv477↗

Trials 1

  1. BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer Principal investigator NCT01571024↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nancy Porterfield Kren · 2 shared papers, 2020–2022 · strength 0.28
  2. Yuliya Pylayeva-Gupta · 2 shared papers, 2020–2022 · strength 0.28
  3. Paul A Dayton · 1 shared paper, 2022 · strength 0.19
  4. Jordan B. Joiner · 1 shared paper, 2022 · strength 0.19
  5. Kristina Drizyte‐Miller · 1 shared paper, 2023 · strength 0.13
  6. Bjoern Papke · 1 shared paper, 2023 · strength 0.13
  7. Emanuel F. Petricoin · 1 shared paper, 2023 · strength 0.13
  8. Mariaelena Pierobon · 1 shared paper, 2023 · strength 0.13
  9. Kirsten L. Bryant · 1 shared paper, 2023 · strength 0.13
  10. Adrienne D. Cox · 1 shared paper, 2023 · strength 0.13
  11. Jennifer E. Klomp · 1 shared paper, 2023 · strength 0.13
  12. Clint A. Stalnecker · 1 shared paper, 2023 · strength 0.13
  13. Andrew M. Waters · 1 shared paper, 2023 · strength 0.13
  14. Channing J. Der · 1 shared paper, 2023 · strength 0.13
  15. Craig M. Goodwin · 1 shared paper, 2023 · strength 0.13
  16. Daniel E. Michaud · 1 shared paper, 2020 · strength 0.09
  17. William G. Hawkins · 1 shared paper, 2020 · strength 0.09
  18. Naim U. Rashid · 1 shared paper, 2020 · strength 0.09
  19. Bhalchandra Mirlekar · 1 shared paper, 2020 · strength 0.09
  20. Jen Jen Yeh · 1 shared paper, 2020 · strength 0.09
  21. Ryan C Fields · 1 shared paper, 2020 · strength 0.09
  22. David G DeNardo · 1 shared paper, 2020 · strength 0.09
  23. Deirdre Jill Cohen · 2 shared papers, 2015 · strength 0.07
  24. Bert H. O’Neil · 2 shared papers, 2015 · strength 0.07
  25. Antonio Jimeno · 2 shared papers, 2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.